VEGFA and neoplasm: The anti-angiogenic effect of propranolol is shown in IH [8] and in vitro with the reduction in Hypoxia Inducible Factor (HIF) levels and vascular endothelial growth factor (VEGF) secretion and thus impairment of the tumor-related angiogenic process [24,25,26,27].